<DOC>
	<DOC>NCT01765452</DOC>
	<brief_summary>The Aim of this study is to prove non-inferiority of Closone to the Combination treatment of Plavix with Astrix.</brief_summary>
	<brief_title>Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Subjects under a stable condition after PostPercutaneous Coronary Artery Intervention over three months 20~86 years old Willing to adhere to protocol requirements and sign a informed consent form Subject who did not undergo or failed DrugStent Implantation Subjects who took an anticoagulant, antithrombotic regularlly( â‰¥ 2weeks in a month) before the study, or plan to have continuous treatment during the study(Except Aspirin alone or combination of Aspirin and Clopidogrel) Subjects with a history of substance or alchol abuse Subjects with a history of hypersensitivity to Clopidogrel, Aspirin or other NSAIDS Subjects having Aspirin or other NSAIDsinduced Asthma or history Subjects with Severe hepatopathy(AST and ALT &gt; 5 times the upper limit of normal) Subjects with Severe nephropathy(Cr &gt; 3 times the upper limit of normal) Subjects with hemorrhage like gastric ulcer, intracranial hemorrhage etc. Subjects with high risk of hemorrhage like blood coagulation disorders, uncontrolled severe hypertension, active bleeding, history of severe bleeding subjects who are pregnant, breastfeeding Subjects not using medically acceptable birth control Subjects who are unsuitable to take the Investigational product due to a medical/mental condition Subjects inherently having Galactose malobsorption, Lactase deficiency or GlucoseGalactose malobsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>